Statin use is associated with improved survival in patients with advanced heart failure receiving resynchronization therapy

Andrew D. Sumner, John P. Boehmer, Leslie A. Saxon, Peter Carson, Arthur M. Feldman, Elizabeth Galle, Michael R. Bristow

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

It is unknown whether statin use improves survival in patients with advanced chronic heart failure (HF) receiving cardiac resynchronization therapy (CRT). The authors retrospectively assessed the effect of statin use on survival in patients with advanced chronic HF receiving CRT alone (CRT-P) or CRT with implantable cardioverter-defibrillator therapy (CRT-D) in 1520 patients with advanced chronic HF from the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial database. Six hundred three patients (40%) were taking statins at baseline. All-cause mortality was 18% in the statin group and 22% in the no statin group (hazard ratio [HR] 0.85; confidence interval (CI), 0.67 - 1.07; P = .15). In a multivariable analysis controlling for significant baseline characteristics and use of CRT-P/CRT-D, statin use was associated with a 23% relative risk reduction in mortality (HR, 0.77; CI, 0.61-0.97; P = .03). Statin use is associated with improved survival in patients with advanced chronic HF receiving CRT. No survival benefit was seen in patients receiving statins and optimal pharmacologic therapy without CRT.

Original languageEnglish (US)
Pages (from-to)159-164
Number of pages6
JournalCongestive Heart Failure
Volume15
Issue number4
DOIs
StatePublished - 2009

All Science Journal Classification (ASJC) codes

  • Emergency Medicine
  • Emergency
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Statin use is associated with improved survival in patients with advanced heart failure receiving resynchronization therapy'. Together they form a unique fingerprint.

Cite this